10min chapter

Let’s Talk Medtech cover image

Guardant Health's Meteoric Rise in Cancer Detection

Let’s Talk Medtech

CHAPTER

Revolutionizing Cancer Diagnostics

This chapter examines the FDA approval of the Guardian 360 CDX as a companion diagnostic, marking a pivotal shift from invasive biopsies to blood tests for cancer detection. It discusses the implications for HER2 mutated lung cancer patients and the importance of innovative testing solutions like Guarded Reveal for monitoring cancer recurrence.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode